Guidewire Software, Inc. filed a Form 8-K with the SEC on September 3, 2026, disclosing its financial results for the fiscal quarter and year ended July 31, 2026, and announcing the planned retirement of its Chief Accounting Officer.
Northwest Natural Holding Company and its subsidiary Northwest Natural Gas Company filed a current report on September 3, 2026, disclosing the issuance of $120,000,000 in aggregate principal amount of First Mortgage Bonds in two tranches to institutional investors.
The Scotts Miracle-Gro Company filed a Form 8-K on September 3, 2026, disclosing that Executive Vice President and Chief Strategy Officer Christopher J. Hagedorn will depart the company effective September 30, 2026.
IDEX Corporation filed a current report on September 3, 2026, disclosing that it amended and restated its revolving credit facility, extending the maturity to 2031 and maintaining an aggregate principal amount of $800 million.
Concrete Pumping Holdings, Inc. filed a Form 8-K on September 3, 2026, reporting its third-quarter fiscal year 2026 financial results and announcing that its Board of Directors has approved a new regular quarterly cash dividend program.
Zscaler, Inc. filed a Form 8-K on September 3, 2026, disclosing a workforce restructuring plan committed to on September 1, 2026, and announcing the release of its financial results for the fourth fiscal quarter and fiscal year ended July 31, 2026.
Andre Almeida, Chief Commercial Officer of T-Mobile US, Inc., filed a Form 4 on September 3, 2026, disclosing that 530.438 shares of common stock were withheld on September 1, 2026, to cover taxes upon the vesting of restricted stock units.
Graphic Packaging Holding Company filed a Form 8-K with the SEC on September 3, 2026, disclosing that its primary operating subsidiary entered into a loan agreement tied to $115.2 million in tax-exempt green bonds due 2064.
Herc Holdings Inc. filed a Form 8-K on September 3, 2026, disclosing that its subsidiary Herc Rentals Inc. entered into a Ninth Amendment to its Receivables Financing Agreement on August 31, 2026, extending the facility's maturity date and increasing borrowing availability.
Teva Pharmaceutical Industries Limited filed a current report on September 3, 2026, disclosing a material modification to the rights of security holders in connection with the planned termination of its American depositary share program and the direct listing of its ordinary shares on the …